Gabriella Alexandersson von Döbeln

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ANNALS OF ONCOLOGY. 2023;34(11):1015-1024
Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial
Nilsson K; Klevebro F; Sunde B; Rouvelas I; Lindblad M; Szabo E; Halldestam I; Smedh U; Wallner B; Johansson J; Johnsen G; Aahlin EK; Johannessen H-O; von Doebeln GA; Hjortland GO; Wang N; Shang Y; Borg D; Quaas A; Bartella I; Bruns C; Schroeder W; Nilsson M
Article: CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY. 2023;40:100610
Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study
Olafsdottir HS; Dalqvist E; Onjukka E; Klevebro F; Nilsson M; Gagliardi G; von Dobeln GA
Article: CANCERS. 2023;15(9):2543
Radiotherapy-Dose Escalated for Large Volume Primary Tumors-And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck-A Randomized Phase II Trial
Mercke C; Wickart-Johansson G; Sjodin H; Farrajota Neves da Silva P; von Dobeln GA; Margolin G; Jonmarker Jaraj S; Carstens H; Berglund A; Lax I; Hellstrom M; Hammarstedt-Nordenvall L; Friesland S
Article: FRONTIERS IN ONCOLOGY. 2022;12:917961
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
Nilsson M; Olafsdottir H; Alexandersson von Doebeln G; Villegas F; Gagliardi G; Hellstroem M; Wang Q-L; Johansson H; Gebski V; Hedberg J; Klevebro F; Markar S; Smyth E; Lagergren P; Al-Haidari G; Rekstad LC; Aahlin EK; Wallner B; Edholm D; Johansson J; Szabo E; Reynolds JV; Pramesh CS; Mummudi N; Joshi A; Ferri L; Wong RKS; O'Callaghan C; Lukovic J; Chan KKW; Leong T; Barbour A; Smithers M; Li Y; Kang X; Kong F-M; Chao Y-K; Crosby T; Bruns C; van Laarhoven H; van Berge Henegouwen M; van Hillegersberg R; Rosati R; Piessen G; de Manzoni G; Lordick F
Article: RADIATION ONCOLOGY. 2021;16(1):153
Short-course compared to long-course palliative radiotherapy for oesophageal cancer: a single centre observational cohort study
Olafsdottir HS; Klevebro F; Ndegwa N; Alexandersson von Dobeln G
Article: CANCER TREATMENT AND RESEARCH COMMUNICATIONS. 2020;24:100187
Definitive chemoradiotherapy plus cetuximab for cancer in the oesophagus or gastro-oesophageal junction.
von Döbeln GA; Wagenius G; Holtved E; Jacobsen A-B; Nilsson M; Yu J; Baeksgaard L
Article: FRONTIERS IN ONCOLOGY. 2020;10:1647
Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study
Onjukka E; Mercke C; Bjorgvinsson E; Embring A; Berglund A; Alexandersson von Dobeln G; Friesland S; Gagliardi G; Lenneby Helleday C; Sjodin H; Lax I
Article: DISEASES OF THE ESOPHAGUS. 2019;32(2):doy078
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
von Dobeln GA; Klevebro F; Jacobsen A-B; Johannessen H-O; Nielsen NH; Johnsen G; Hatlevoll I; Glenjen NI; Friesland S; Lundell L; Yu J; Nilsson M
Article: PRACTICAL RADIATION ONCOLOGY. 2016;6(3):e53-e59
Pulmonary function and cardiac stress test after multimodality treatment of esophageal cancer.
von Döbeln GA; Nilsson M; Adell G; Johnsen G; Hatlevoll I; Tsai J; Lundell L; Lund M; Lind P
Article: ANNALS OF ONCOLOGY. 2016;27(4):660-667
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
Klevebro F; von Dobeln GA; Wang N; Johnsen G; Jacobsen A-B; Friesland S; Hatlevoll I; Glenjen NI; Lind P; Tsai JA; Lundell L; Nilsson M
Article: RADIATION ONCOLOGY. 2015;10:16
Effects on heart function of neoadjuvant chemotherapy and chemoradiotherapy in patients with cancer in the esophagus or gastroesophageal junction - a prospective cohort pilot study within a randomized clinical trial
Lund M; von Dobeln GA; Nilsson M; Winter R; Lundell L; Tsai JA; Kalman S

Alla övriga publikationer

Letter: DISEASES OF THE ESOPHAGUS. 2019;32(3):doy101
Reply to letter: Neoadjuvant chemoradiotherapy or chemotherapy for esophageal cancer: what is the current evidence?
von Dobeln GA; Klevebro F; Nilsson M
Thesis / dissertation: 2018
Multimodality treatment of oesophageal cancer : effects and side effects
Alexandersson von Döbeln, Gabriella

Anställningar

Anknuten till Forskning, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2024-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2018

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI